Dutch Health Council advice 'Vaccination against pneumococcal infections in elderly persons and immunocompromised adults;Gezondheidsraadadvies 'Vaccinatie tegen pneumokokken bij ouderen en risicogroepen'

Nederlands Tijdschrift voor Geneeskunde

Volumn 148, Issue 18, 2004, Pages 871-874

  Kullberg, B J ^a,b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Nijmeegs Univ Ctr V Infectieziek   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE;

AGED; ASPLENIA; CEREBROSPINAL FLUID FISTULA; CHRONIC RESPIRATORY TRACT DISEASE; DIABETES MELLITUS; HEART FAILURE; HUMAN; IMMUNE DEFICIENCY; MEDICAL SOCIETY; NETHERLANDS; REVIEW; SICKLE CELL ANEMIA; SOLID TUMOR; STREPTOCOCCUS INFECTION; TREATMENT INDICATION; VACCINATION;

AGED; EVIDENCE-BASED MEDICINE; HUMANS; IMMUNOCOMPROMISED HOST; NETHERLANDS; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES;

EID: 2442513353     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. Bosch WJHM van den. Pneumokokkenvaccinatie voor personen vanaf 65 jaar. Ned Tijdschr Geneeskd 2002;146:838-9.
2. Gezondheidsraad. Vaccinatie tegen pneumokokken bij ouderen en risicogroepen. Publicatienr 2003/10. Den Haag: Gezondheidsraad; 2003.
3. Bohte R, Furth R van, Broek PJ van den. Aetiology of community-acquired pneumonia: a prospective study among adults requiring admission to hospital. Thorax 1995;50:543-7.
4. Jonkers RE, Boersma WG. Pneumokokkenvaccinatie van volwassenen. Ned Tijdschr Geneeskd 2003;147:437-41.
5. Haveman LM, Geelen SPM, Sanders EAM, Wolfs TFW. Ernstige pneumokokkeninfecties bij jonge kinderen: het belang van vaccinatie. Ned Tijdschr Geneeskd 2002;146:1917-20.
6. Gezondheidsraad. Algemene vaccinatie tegen meningokokken C en pneumokokken. Publicatienr 2001/27. Den Haag: Gezondheidsraad; 2001.
7. Hutchison BG, Oxman AD, Shannon HS, Lloyd S, Altmayer CA, Thomas K. Clinical effectiveness of pneumococcal vaccine. Metaanalysis. Can Fam Physician 1999;45:2381-93.
8. Honkanen PO, Keistinen T, Miettinen L, Herva E, Sankilampi U, Laara E, et al. Incremental effectiveness of pneumococcal vaccine on simultaneously administered influenza vaccine in preventing pneumonia and pneumococcal pneumonia among persons aged 65 years or older. Vaccine 1999;17:2493-500.
9. Koivula I, Sten M, Leinonen M, Makela PH. Clinical efficacy of pneumococcal vaccine in the elderly: a randomized, single-blind population-based trial. Am J Med 1997;103:281-90.
10. Fine MJ, Smith MA, Carson CA, Meffe F, Sankey SS, Weissfeld LA, et al. Efficacy of pneumococcal vaccination in adults. A metaanalysis of randomized controlled trials. Arch Intern Med 1994;154:2666-77.
11. Watson L, Wilson BJ, Waugh N. Pneumococcal polysaccharide vaccine: a systematic review of clinical effectiveness in adults. Vaccine 2002;20:2166-73.
12. Moore RA, Wiffen PJ, Lipsky BA. Are the pneumococcal polysaccharide vaccines effective? Meta-analysis of the prospective trials. BMC Fam Pract 2000;1:1.
13. Assendelft WJJ, Scholten RJPM, Offringa M. Pneumococcal vaccination for the elderly in the Netherlands? Assessment of the quality and content of available comparative studies. Neth J Med 2004;62:36-44.
14. Lipsky BA, Hirschmann JV. Pneumococcal polysaccharide vaccines do not protect the elderly from pneumococcal infections. Neth J Med 2004;62:33-5.
15. Dear K, Holden J, Andrews R, Tatham D. Vaccines for preventing pneumococcal infection in adults [Cochrane review]. The Cochrane Library. Issue 4. Chichester: Wiley; 2004.
16. Jackson LA, Neuzil KM, Yu O, Benson P, Barlow WE, Adams AL, et al. Effectiveness of pneumococcal polysaccharide vaccine in older adults. N Engl J Med 2003;348:1747-55.
17. French N, Nakiyingi J, Carpenter LM, Lugada E, Watera C, Moi K, et al. 23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial. Lancet 2000;355:2106-11.
18. Simberkoff MS, Cross AP, Al-Ibrahim M, Baltch AL, Geiseler PJ, Nadler J, et al. Efficacy of pneumococcal vaccine in high-risk patients. Results of a Veterans Administration Cooperative Study. N Engl J Med 1986;315:1318-27.
19. Ortqvist A, Hedlund J, Burman LA, Elbel E, Hofer M, Leinonen M, et al. and the Swedish Pneumococcal Vaccination Study Group. Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people. Lancet 1998;351:399-403.
20. Baltussen A, Ament A, Leidl R, Furth R van. Kosteneffectiviteit van pneumokokkenvaccinatie van ouderen. Ned Tijdschr Geneeskd 1997;141:2188-92.
21. Postma MJ, Heijnen MLA, Beutels Ph, Jager JC. Farmaco-economische aspecten van vaccinatie tegen invasieve pneumokokkeninfecties bij 65-plussers; literatuuroverzicht van kosteneffectiviteits-analysen. Ned Tijdschr Geneeskd 2002;146:855-9.
22. Sisk JE, Whang W, Butler JC, Sneller VP, Whitney CG. Cost-effectiveness of vaccination against invasive pneumococcal disease among people 50 through 64 years of age: role of comorbid conditions and race. Ann Intern Med 2003;138:960-8.
23. Ament AJHA, Sprenger M, Botman MJ, Sasburg RH, Waard J de. Kosten-batenanalyse van vaccinatie tegen pneumokokkenpneumonie. Ned Tijdschr Geneeskd 1986;130:407-10.
24. Vries PAM de, Oei-Reyners AKL, Möller AVM, Timens W, Tulleken JE, Werf TS van der. Fulminante pneumokokkensepsis bij twee postsplenectomiepatiënten. Ned Tijdschr Geneeskd 2003;147: 450-4.
25. Melles DC, Marie S de. Prevention of infections in hyposplenic and asplenic patients: an update. Neth J Med 2004;62:45-52.